The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
Research on CAR T cells has achieved enormous progress in recent years. After the impressive results obtained in relapsed and refractory B-cell acute lymphoblastic leukemia and aggressive B-cell lymphomas, two constructs, tisagenlecleucel and axicabtagene ciloleucel, were approved by FDA. The role o...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| 格式: | Revisão |
| 语言: | 英语 |
| 出版: |
2020
|
| 在线阅读: | https://doi.org/10.3389/fimmu.2020.00888 https://www.frontiersin.org/articles/10.3389/fimmu.2020.00888/pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|